Session topics and Invited Speakers at EuPAT 12
June 16-18 • 2025 • Kuopio • Finland
16th June – Workshop Manufacturing of viral vectors: Lessons learnt and future perspectives
17th June – Session 1 Latest Approaches in Advanced Drug Delivery Systems
17th June – Session 2 Innovations in Manufacturing and Measurement Science
18th June – Session 3 From Science to Sustainable Manufacturing Solutions
Programme
16 June – Pre-conference workshop "Manufacturing of viral vectors: Lessons learnt and future perspectives"
Aled Jones, FinVector Oy, Introduction to commercial manufacturing of viral vectors
Mari Tenhunen, Timegate Instruments Oy, Raman spectroscopy in biodrug development and manufacturing
Vijay Saxena, University of Eastern Finland, Protein engineering applications for biopharmaceutical development
Albert Mihranyan, Uppsala University, Zooming the process: Where biomanufacturing meets patient value
Ossi Korhonen, University of Eastern Finland, Does freeze drying bring any added value to biodrug life cycle?
Thomas de Beer, RheaVita BV / Ghent University, Continuous freeze drying, the next step in downstream processing of biodrugs
17 June – Session 1: “Latest Approaches in Advanced Drug Delivery Systems”
Vincenzo Cerullo, Valo Therapeutics / Helsinki University, FI, Dressing up to fool cancer: novel platforms for personalized cancer vaccines
Camilla Foged, University of Copenhagen, DK, Next-generation delivery systems for mRNA vaccines
Yvonne Perrie, University of Strathclyde, UK, Understanding the structure-function of lipid nanoparticles for the delivery of mRNA
17 June – Session 2: “Innovations in Manufacturing and Measurement Science”
Clare Strachan, Helsinki University, FI, Revealing hidden microscale phenomena in pharmaceuticals with nonlinear optics
Julian Quodbach, Utrecht University, NL, Growing up or dying out? Pharmaceutical 3D printing in industry and clinics
Reto Maurer, F. Hoffmann – La Roche AG, Basel, CH, The Mini-Batch concept - addressing the challenges of continuous direct compression
Moritz Anuschek, NovoNordisk A/S, DK, PAT in solid sosage form manufacturing – Current status and future perspectives
18 June – Session 3: “From Science to Sustainable Manufacturing Solutions”
Nigel Parker, GeneCellNano Flagship, FI, Lab to commercialisation – Financing aspects
Jo Dewulf, Ghent University, BE, Steering the pharmaceutical sector towards sustainability
Piia Valonen, FinVector Oy, FI, Industrialisation of adenoviral vector production in fixed bed bioreactor: A control strategy for a monoseptic process
Luther Gwaza, WHO, CH, Some insights to continuous manufacturing guidelines
Participants are encouraged to Submit Abstracts for poster presentations, whilst selected scientists from submitted abstracts will be invited to give oral presentations alongside the keynote speakers!
